SEC Form 4 · accession 0001104659-15-049326
SYNERGY PHARMACEUTICALS, INC. · SGYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary S Jacob
Officer — Chief Executive Officer · Director
Period of report
Jul 1, 2015
Accepted (ET)
Jul 1, 2015 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2015 | M | 62,965 | $5.61 | A | 396,999 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $5.61 | Jul 1, 2015 | M | 62,965 | D | — | Jul 6, 2015 | Common Stock | 62,965 | 4,135,177 | D |
Explanation of responses
- F1Fully vested